Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice

Diabetes

Volumn 62, Issue 5, 2013, Pages 1681-1688

  Leboucher, Antoine ^a,b   Laurent, Cyril ^a,b   Fernandez Gomez, Francisco José ^a,b   Burnouf, Sylvie ^a,b   Troquier, Laetitia ^a,b   Eddarkaoui, Sabiha ^a,b   Demeyer, Dominique ^a,b   Caillierez, Raphaëlle ^a,b   Zommer, Nadège ^a,b   Vallez, Emmanuelle ^a,c,d   Bantubungi, Kadiombo ^a,c,d   Breton, Christophe ^a,e   Pigny, Pascal ^a,b,f   Buée Scherrer, Valérie ^a,b   Staels, Bart ^a,c,d   Hamdane, Malika ^a,b   Tailleux, Anne ^a,c,d   Bueé, Luc ^a,b,f   Blum, David ^a,b,f  

^a UNIV LILLE   (France)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^c INSERM   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e UNIVERSITÉ DE LILLE   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPATIAL LEARNING; SPATIAL MEMORY; UPREGULATION;

ANIMALS; BEHAVIOR, ANIMAL; DIET, HIGH-FAT; HIPPOCAMPUS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LEARNING DISORDERS; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; OBESITY; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; SPATIAL BEHAVIOR; TAU PROTEINS; TAUOPATHIES; UP-REGULATION;

EID: 84876572014     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0866     Document Type: Article

References (37)

1. Sergeant N, Bretteville A, Hamdane M, et al. Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev Proteomics 2008;5:207-224 (Pubitemid 351670926)
2. Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011;70:960-969
3. Grober E, Dickson D, Sliwinski MJ, et al. Memory and mental status correlates of modified Braak staging. Neurobiol Aging 1999;20:573-579 (Pubitemid 30064402)
4. Frisardi V, Solfrizzi V, Seripa D, et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 2010;9:399-417
5. Pasinetti GM, Eberstein JA. Metabolic syndrome and the role of dietary lifestyles in Alzheimer' s disease. J Neurochem 2008;106:1503-1514
6. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008;71:1057-1064
7. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556-1560 (Pubitemid 41434560)
8. Mrak RE. Alzheimer-type neuropathological changes in morbidly obese elderly individuals. Clin Neuropathol 2009;28:40-45
9. Mielke JG, Taghibiglou C, Liu L, et al. A biochemical and functional characterization of diet-induced brain insulin resistance. J Neurochem 2005;93:1568-1578 (Pubitemid 40853280)
10. Moroz N, Tong M, Longato L, Xu H, de la Monte SM. Limited Alzheimertype neurodegeneration in experimental obesity and type 2 diabetes mellitus. J Alzheimers Dis 2008;15:29-44
11. Pratchayasakul W, Kerdphoo S, Petsophonsakul P, Pongchaidecha A, Chattipakorn N, Chattipakorn SC. Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Sci 2011;88:619-627
12. Schubert M, Brazil DP, Burks DJ, et al. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 2003;23:7084-7092 (Pubitemid 36975873)
13. Schubert M, Gautam D, Surjo D, et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 2004;101:3100-3105 (Pubitemid 38327741)
14. Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, Gong C-X. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease. Am J Pathol 2009;175:2089-2098
15. Grünblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 2007;101:757-770 (Pubitemid 46633313)
16. Schindowski K, Bretteville A, Leroy K, et al. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 2006;169:599-616 (Pubitemid 44156317)
17. Belarbi K, Burnouf S, Fernandez-Gomez F-J, et al. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. Neurobiol Dis 2011;43:486-494
18. Le Freche H, Brouillette J, Fernandez-Gomez F-J, et al. Tau phosphorylation and sevo flurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology 2012;116:779-787
19. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer 's disease. Arch Neurol 1995;52:81-88
20. Rosenmann H, Grigoriadis N, Eldar-Levy H, et al. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Exp Neurol 2008;212:71-84
21. Van der Jeugd A, Ahmed T, Burnouf S, et al. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol Learn Mem 2011;95:296-304
22. Busceti CL, Biagioni F, Riozzi B, et al. Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine ("Ecstasy"). J Neurosci 2008;28:3234-3245 (Pubitemid 351442298)
23. Santacruz K, Lewis J, Spires T, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005;309:476-481 (Pubitemid 40994688)
24. Kyoung Pyo H, Lovati E, Pasinetti GM, Ksiezak-Reding H. Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: the role of AKT. Neuroscience 2004;127:649-658 (Pubitemid 38993168)
25. Griffin RJ, Moloney A, Kelliher M, et al. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem 2005;93:105-117 (Pubitemid 40463520)
26. Ksiezak-Reding H, Pyo HK, Feinstein B, Pasinetti GM. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro. Biochim Biophys Acta 2003;1639:159-168 (Pubitemid 37421423)
27. Pei J-J, Khatoon S, An W-L, et al. Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol 2003;105:381-392 (Pubitemid 36798832)
28. Yoshimura Y, Ichinose T, Yamauchi T. Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca2+/calmodulin- dependent protein kinase II as demonstrated tandem mass spectrometry. Neurosci Lett 2003;353:185-188 (Pubitemid 37510173)
29. Singh TJ, Grundke-Iqbal I, Wu WQ, et al. Protein kinase C and calcium/calmodulin-dependent protein kinase II phosphorylate three-repeat and four-repeat tau isoforms at different rates. Mol Cell Biochem 1997;168:141-148 (Pubitemid 27091065)
30. Wang J-Z, Grundke-Iqbal I, Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 2007;25:59-68 (Pubitemid 46098893)
31. Talbot K, Wang H-Y, Kazi H, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122:1316-1338
32. de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 2012;9:35-66
33. Becker K, Freude S, Zemva J, Stöhr O, Krone W, Schubert M. Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in vivo. Neurosci Lett 2012;516:306-310
34. Jeon BT, Jeong EA, Shin HJ, et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012;61:1444-1454
35. Killick R, Scales G, Leroy K, et al. Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice. Biochem Biophys Res Commun 2009;386:257-262
36. Glöckner F, Meske V, Lütjohann D, Ohm TG. Dietary cholesterol and its effect on tau protein: a study in apolipoprotein E-deficient and P301L human tau mice. J Neuropathol Exp Neurol 2011;70:292-301
37. Boimel M, Grigoriadis N, Lourbopoulos A, et al. Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J Neuropathol Exp Neurol 2009;68:314-325